These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15099018)

  • 1. Meningioma pathology, genetics, and biology.
    Lamszus K
    J Neuropathol Exp Neurol; 2004 Apr; 63(4):275-86. PubMed ID: 15099018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Meningiomas: anatomical pathology and molecular biology].
    Bekiashev AKh; Korshunov AG; Cherekaev VA
    Arkh Patol; 2007; 69(5):48-54. PubMed ID: 18074823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological classification and molecular genetics of meningiomas.
    Riemenschneider MJ; Perry A; Reifenberger G
    Lancet Neurol; 2006 Dec; 5(12):1045-54. PubMed ID: 17110285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of meningiomas-advances and controversies.
    Harter PN; Braun Y; Plate KH
    Chin Clin Oncol; 2017 Jul; 6(Suppl 1):S2. PubMed ID: 28595423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
    Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
    Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningiomas: A continuum of progress in risk-stratification.
    Chacko G
    Neurol India; 2018; 66(1):161-162. PubMed ID: 29322979
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathological classification and molecular genetics of meningiomas.
    Mawrin C; Perry A
    J Neurooncol; 2010 Sep; 99(3):379-91. PubMed ID: 20809251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meningioma. Classification and grading].
    Niedermayer I; Kolles H; Henn W; Zang KD; Steudel WI; Feiden W
    Pathologe; 1997 Sep; 18(5):353-8. PubMed ID: 9432670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal instability mapping in meningioma.
    K Roukas D; Ragos V; S Mastronikolis N; Tsiambas E
    J BUON; 2018; 23(6):1931. PubMed ID: 30610828
    [No Abstract]   [Full Text] [Related]  

  • 11. [The molecular genetics of meningiomas and genotypic/phenotypic correlations].
    Dezamis E; Sanson M
    Rev Neurol (Paris); 2003 Sep; 159(8-9):727-38. PubMed ID: 13679715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology and molecular genetics of meningioma: recent advances.
    Shibuya M
    Neurol Med Chir (Tokyo); 2015; 55(1):14-27. PubMed ID: 25744347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas.
    Boetto J; Bielle F; Sanson M; Peyre M; Kalamarides M
    Neuro Oncol; 2017 Mar; 19(3):345-351. PubMed ID: 28082415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis of meningiomas.
    Perry A; Gutmann DH; Reifenberger G
    J Neurooncol; 2004 Nov; 70(2):183-202. PubMed ID: 15674477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas.
    Cordova C; Kurz SC
    Curr Oncol Rep; 2020 Jul; 22(8):84. PubMed ID: 32617743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histopathological spectrum of human meningiomas.
    Backer-Grøndahl T; Moen BH; Torp SH
    Int J Clin Exp Pathol; 2012; 5(3):231-42. PubMed ID: 22558478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of meningiomas.
    Langford LA
    J Neurooncol; 1996 Sep; 29(3):217-21. PubMed ID: 8858527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in the pathology of skull base tumors.
    Radner H; Katenkamp D; Reifenberger G; Deckert M; Pietsch T; Wiestler OD
    Virchows Arch; 2001 Apr; 438(4):321-35. PubMed ID: 11355165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMARCE1 mutation screening in classification of clear cell meningiomas.
    Smith MJ; Ahn S; Lee JI; Bulman M; Plessis DD; Suh YL
    Histopathology; 2017 Apr; 70(5):814-820. PubMed ID: 27891692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.